FEATURED COMPANIES
- A&D Medical
- Boston Scientific
- GE Healthcare
- Medtronic
- Philips Lifeline
- Sibelmed
mHealth and Home Monitoring is the ninth consecutive report that gives first-hand insights into the adoption of wireless solutions for health monitoring.
This strategic research report provides you with 300 pages of unique business intelligence including 5-year industry forecasts and expert commentary on which to base your business decisions.
This report will allow you to:
- Profit from 30 new executive interviews with market leading companies.
- Learn about key home health monitoring devices and services.
- Study the strategies of 130 key players in the mHealth ecosystem. Understand the dynamics of the health monitoring market in Europe and North America.
- Comprehend how wireless technology can become seamlessly integrated with medical devices.
- Evaluate the business opportunities in the emerging mHealth segment.
- Predict future market and technology developments.
This report answers the following questions:
- Which medical conditions offer the best potential for wireless health monitoring solutions?
- Who are the leading providers of connected medical devices?
- What are the mHealth strategies of medical device vendors and pharmaceutical companies?
- Which are the general technology trends for home health monitoring equipment?
- What initiatives have been taken by the leading players in the telecom and IT industries?
- How can connectivity redefine the use cases of medical devices and the value propositions to patients and other stakeholders?
- What are the market shares of the top 5 integrated telehealth solution vendors?
- Why are smartphone applications so significant for the mHealth market?
- How can healthcare providers and payers benefit from mHealth solutions?
Who should buy this report?
mHealth and Home Monitoring is the foremost source of information about the adoption of wireless solutions for health monitoring. Whether you are a medical equipment vendor, telecom operator, healthcare provider, investor, consultant, or government agency, you will gain valuable insights from our indepth research.
FEATURED COMPANIES
- A&D Medical
- Boston Scientific
- GE Healthcare
- Medtronic
- Philips Lifeline
- Sibelmed
LOADING...
FEATURED COMPANIES
- A&D Medical
- Boston Scientific
- GE Healthcare
- Medtronic
- Philips Lifeline
- Sibelmed
The number of remotely monitored patients grew by 41 percent to 16.5 million in 2017 as the market acceptance continues to grow in several key verticals. This number includes all patients enrolled in mHealth care programs in which connected medical devices are used as a part of the care regimen. Connected medical devices used for various forms of personal health tracking are not included in this figure. The researcher estimates that the number of remotely monitored patients will grow at a compound annual growth rate (CAGR) of 31.0 percent to reach 83.4 million by 2023. The two main applications are monitoring of patients with sleep therapy devices and monitoring of patients with implantable cardiac rhythm management (CRM) devices. These two segments accounted for 82 percent of all connected home medical monitoring systems in 2017.
The number of remotely monitored sleep therapy patients grew by 37 percent in 2017, mainly driven by Philips and ResMed that together dominate the sleep therapy market. The CRM market is led by companies such as Medtronic, Boston Scientific and Abbott that started to include connectivity in CRM solutions more than a decade ago. Telehealth is the third largest segment with 0.8 million connections at the end of the year. Leading telehealth hub vendors include Tunstall Healthcare, Resideo (Honeywell), Medtronic, Philips and Qualcomm Life. Other device categories – including ECG, glucose level, medication compliance, blood pressure monitors and others – accounted for just over two million connections. “The most promising segment is medication compliance, which we expect will become the second most connected segment in the next five years”, says Sebastian Hellström, IoT Analyst. More than 60 percent of all connected medical monitoring devices rely on cellular connectivity today and has become the de-facto standard for most types of connected home medical monitoring devices.
The number of mHealth devices with integrated cellular connectivity increased from 7.1 million in 2016 to 10.7 million in 2017. The use of BYOD connectivity will increase the most during the next six years, with a forecasted CAGR of 48.2 percent. “BYOD involves low cost and the technology is mostly adopted in patient-centric therapeutic areas such as diabetes and asthma that have younger patient demographics compared to many other chronic diseases. Many of these patients prefer to use their own smartphone as the interface instead of carrying around a dedicated device for remote monitoring”, concluded Mr. Hellström.
A selection of companies mentioned in this report includes:
- A&D Medical
- AEDMAP
- AT&T
- Abbott (St. Jude Medical)
- AdhereTech
- Adherium
- Aeon Global Health
- Aerotel Medical Systems
- AliveCor
- Almas Industries
- Alphabet
- Apple
- Ascensia Diabetes Care
- AstraZeneca
- Bepatient
- BioTelemetry
- Biotronik
- BodyTel
- Boston Scientific
- Cadwell Laboratories
- CardiLink
- Cardia International
- CardioComm Solutions
- Care Innovations
- ChoiceMMed
- Circassia Pharmaceuticals
- Clement Clarke International
- CleveMed
- CoaguSense
- Compliance Meds Technologies
- Compumedics
- DayaMed
- Deutsche Telekom
- Dexcom
- Domicalis
- Drive DeVilbiss Healthcare
- ERT (Exco InTouch)
- Ericsson
- Evondos
- Fisher & Paykel Healthcare
- GE Healthcare
- Get Real Health
- Glooko
- H2AD
- Helena Laboratories
- iHealth Labs
- Infoscan
- iLine MicrosystemsIdeal Life
- Instrumentation Laboratory (Accriva Diagnostics)
- Insulet
- iRhythm TechnologiesInRange Systems
- Johnson & Johnson
- KORE
- Laerdal Medical
- LevMed
- LindaCare
- Livongo Health
- Löwenstein Medical Technology
- Masimo
- MedM
- Medical International Research
- Medicpen
- Medixine
- Medtronic
- Medvivo
- Merck Group
- Metrax
- MicroPort (LivaNova)
- Microlife
- Microsoft
- Natus Medical
- Ndd Medizintechnik
- Nihon Kohden
- Nonin Medical
- NovaSom
- Nox Medical
- nSpire Health
- Omron Healthcare
- OpenTeleHealth
- Optum
- Orange Healthcare
- PTC
- Philips Enterprise Telehealth
- Philips Lifeline
- Philips Sleep and Respiratory Care
- Physio-Control
- Preventice Solutions
- Propeller Health
- Proteus Digital Health
- Pyrescom
- Qualcomm Life
- QuiO
- ResMed
- Resideo Technologies (Honeywell Life Care Solutions)
- Respiri
- Roche Diagnostics
- Rossmax
- S3 Connected Health
- SHL Telemedicine
- SOMNOmedics
- SRETT
- Schiller
- ScottCare
- Senseonics
- Sibelmed
- Siemens Healthineers
- SleepMed
- SomnoMed
- TZ Medical
- Tactio Health
- Telcare
- Telefónica
- Telenor Connexion
- Tunstall Healthcare Group
- Verklizan
- Vitalograph
- Vitaphone
- Vodafone
- Voluntis
- Welch-Allyn
- WellDoc
- Zenicor
- Zoll Medical Corporation
The Internet of Things is very diverse. There are hundreds of different use cases, each with different dynamics. The starting point is to segment the market.
The analyst begins with a number of sectors: Automotive, Cities, Health, Industry, Home, Industrial, Energy, Retail and Consumer Electronics. Each of these sectors breaks down into a number of applications. In total across all sectors, the analyst examines around 150 separate applications. It is at this application level that they generate their IoT forecast. The analyst builds reliable data bottom-up. They take into consideration the current adoption rate, regulations, demographics, vertical-specific statistics, value chain structure, etc.
The rigorous data collection methods are based on first-hand and secondary sources. The analyst conducts many hundreds of executive interviews on a yearly basis with companies from all parts of the IoT value chain. They talk to on a regular basis all major mobile operator groups and regulators as well as the chipset, module, and terminal vendors. They also interview many companies in each of the vertical markets.
LOADING...